Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production
- PMID: 6324595
- PMCID: PMC1900364
Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production
Abstract
Prostaglandins (PGs) of the E series and PGI2 have been shown to inhibit acute inflammatory reactions in vivo and polymorphonuclear leukocyte (PMN), chemotaxis, lysosomal enzyme release, and superoxide anion (O-2) production in vitro. This inhibition of neutrophil stimulation by PGEs and PGI2 has been correlated with their ability to increase intracellular cyclic adenosine monophosphate (cAMP) levels. However, the mechanism(s) by which PGEs and PGI2 alter the complex biochemical and biophysical events associated with stimulus-response coupling in the neutrophil are not clear. It is reported here that both PGEs and PGI2 in micromolar concentrations inhibit formyl-methionyl-leucyl-phenylalanine (FMLP)- and zymosan-induced lysosomal enzyme secretion and superoxide anion production in a dose-dependent manner. No preincubation time of PMNs with the prostaglandins is required for inhibition. Addition of PGEs 10 seconds or later after FMLP stimulation does not alter the biologic response of the neutrophils to the stimulus, suggesting that the prostaglandin inhibition effects early events associated with stimulus-response coupling in the neutrophil. Prostaglandin inhibition of lysosomal enzyme release by the calcium ionophore A23187 was overcome by increasing the extracellular ionophore and/or calcium concentration, suggesting that PGs may modulate intracellular free calcium levels in a manner similar to that observed with platelets. Inhibition of phorbol myristate acetate (PMA)-induced neutrophil lysosomal enzyme secretion by PGEs and PGI2 was overcome by increasing concentrations of PMA. However, neither PGEs nor PGI2 altered O-2 production by PMA-treated neutrophils. These data indicate a dissociation between PMA-stimulated O-2 production and lysosomal enzyme release. These findings are consistent with the hypothesis that inhibition of neutrophil stimulation by PGEs and PGI2 is a result of increased intracellular cyclic AMP levels and modulation of calcium-dependent events. In addition, the data indicate that there are at least two mechanisms by which PMNs can be stimulated to produce O-2, one inhibited by PGEs and PGI2 and a second independent of prostaglandin modulation.
Similar articles
-
Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):308-15. doi: 10.1007/BF00180656. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2159112
-
Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.Am J Pathol. 1984 Aug;116(2):223-33. Am J Pathol. 1984. PMID: 6087668 Free PMC article.
-
Prostaglandin modulation of N-formylmethionylleucylphenylalanine-induced transmembrane potential changes in rat neutrophils.Biochim Biophys Acta. 1984 Jul 20;804(3):265-74. doi: 10.1016/0167-4889(84)90129-0. Biochim Biophys Acta. 1984. PMID: 6331525
-
Poly-L-arginine and an N-formylated chemotactic peptide act synergistically with lectins and calcium ionophore to induce intense chemiluminescence and superoxide production in human blood leukocytes. Modulation by metabolic inhibitors, sugars, and polyelectrolytes.Inflammation. 1984 Mar;8(1):1-26. doi: 10.1007/BF00918349. Inflammation. 1984. PMID: 6325341 Review.
-
Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils--a potential antiatherosclerotic property of calcium antagonists?Cardiovasc Drugs Ther. 2002 Dec;16(6):515-20. doi: 10.1023/a:1022986331231. Cardiovasc Drugs Ther. 2002. PMID: 12766385 Review.
Cited by
-
Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model.Eur J Med Res. 2012 Jun 7;17(1):14. doi: 10.1186/2047-783X-17-14. Eur J Med Res. 2012. PMID: 22676276 Free PMC article.
-
Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):308-15. doi: 10.1007/BF00180656. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2159112
-
Silibinin (Legalon-70) enhances the motility of human neutrophils immobilized by formyl-tripeptide, calcium ionophore, lymphokine and by normal human serum.Agents Actions. 1990 Mar;29(3-4):239-46. doi: 10.1007/BF01966453. Agents Actions. 1990. PMID: 2111081
-
Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial.Ann Surg. 1986 Apr;203(4):371-8. doi: 10.1097/00000658-198604000-00006. Ann Surg. 1986. PMID: 3516085 Free PMC article. Clinical Trial.
-
Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation.Mol Pharmacol. 2009 Jan;75(1):227-34. doi: 10.1124/mol.108.051003. Epub 2008 Oct 17. Mol Pharmacol. 2009. PMID: 18931035 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources